Kymera Therapeutics Ownership & Insider Activity

Kymera Therapeutics Inc

KYMRNASDAQ

Trade with Public

$111.95

-3.86-3.33%

近くで: Sep 24, 5:00 PM EST

$111.51

-4.30-3.71%

プレマーケット: 8:17 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Kymera Therapeutics Ownership & Insider Activity

Kymera Therapeutics (KYMR) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.6% of shares outstanding. Institutional investors hold 70.6%. Over the past 90 days, insiders made 2 sales worth $1.1M.

Shares Outstanding

83.151M

Shares Float

64.632M

Insider Shares Owned

1.340M

Insider % Owned

1.6%

Institutional Shares Held

58.675M

Institutional % Held

70.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$1.1M total

Net Activity

Net Selling

Net Value (90d)

-$1.1M

Kymera Therapeutics Insider Transactions (Last 6 Months)

すべてのインサイダー取引を見る →

Date	Insider	Title	Type	Shares	Price	Value
Sep 4, 2026	Brian Adams	CHIEF LEGAL OFFICER	SELL	6.371K	$116.83	$744K
Jul 7, 2026	Nello Mainolfi	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$60.54	$5.8M
Jul 1, 2026	Noah Goodman	CHIEF BUSINESS OFFICER	SELL	3.389K	$114.29	$387K
Jul 1, 2026	Nello Mainolfi	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$58.69	$9.1M
Jun 30, 2026	Bruce N Jacobs	CHIEF FINANCIAL OFFICER	SELL	15.731K	$60.15	$8.5M
Jun 29, 2026	Bruce Booth	—	SELL	31.283K	$109.48	$3.4M
Jun 26, 2026	Bruce Booth	—	SELL	513.245K	$110.01	$56.5M
Jun 26, 2026	BVF PARTNERS L PIL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd, BVF GP HOLDINGS LLC, INCIL BVF, MARK LAMPERT	DIRECTOR	SELL	1.631M	$106.50	$173.7M
Jun 25, 2026	Bruce Booth	—	SELL	285.684K	$121.86	$34.8M
Jun 25, 2026	Noah Goodman	CHIEF BUSINESS OFFICER	SELL-OPTIONS	—	$67.53	$465K
Jun 23, 2026	Bruce Booth	—	SELL	398.765K	$110.31	$44.0M
Jun 22, 2026	Bruce Booth	—	SELL	31.798K	$103.75	$3.3M
Jun 22, 2026	Noah Goodman	CHIEF BUSINESS OFFICER	SELL-OPTIONS	—	$60.02	$195K
Jun 17, 2026	Bruce Booth	—	SELL	466.457K	$57.36	$45.1M
May 26, 2026	Jeremy Chadwick	CHIEF OPERATING OFFICER	SELL	17.184K	$79.92	$1.4M
May 11, 2026	Elena Ridloff	—	SELL-OPTIONS	—	$59.10	$167K
Apr 29, 2026	Nello Mainolfi	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$41.63	$2.4M
Apr 22, 2026	Bruce Booth	—	SELL	100.000	$52.20	$455K
Apr 22, 2026	Jeremy Chadwick	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$64.53	$15K
Apr 14, 2026	Noah Goodman	CHIEF BUSINESS OFFICER	SELL	1.347K	$90.00	$121K
Apr 14, 2026	Jeremy Chadwick	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$62.21	$364K
Apr 14, 2026	Bruce Booth	—	SELL	3.135K	$52.09	$764K
Apr 9, 2026	Noah Goodman	CHIEF BUSINESS OFFICER	SELL	7.764K	$54.26	$845K
Mar 31, 2026	Jeremy Chadwick	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$57.54	$1.2M
Mar 31, 2026	Elena Ridloff	—	SELL-OPTIONS	—	$49.78	$855K

More with Benzinga EdgeGet Access

Kymera Therapeutics Inc

Kymera Therapeutics Ownership & Insider Activity

Kymera Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

ニュース

パートナーシップ

ベンジンガ・グローバル

People Also Watch